Table 1.
Bioceramics | Target tissue | Features | Ref |
---|---|---|---|
Hydroxyapatite (HA) | Cementum, Alveolar bone | Similar composition to the inorganic phase of bone Osteoconductive Slow degradation |
29,31 |
tricalcium phosphates (TCP) | Alveolar bone, cementum | Similar composition to the inorganic phase of bone Higher stability Osteoconductive Bioabsorbable Β-TCP: Similar degradation kinetic to the autologous grafts |
32, 33, 34 |
Bioactive glass | Alveolar bone, cementum | Osteoconductive and osteoblast cell differentiation Similar composition to the inorganic phase of bone Biocompatible with the different degradation rate Degradation products improve the osteogenesis, angiogenesis, and antibacterial activities |
28,35,36 |
Nagelschmidtite (Ca7Si2P2O16) | Alveolar bone, cementum | Suitable mechanical properties and degradation rate for spongy bone regeneration Favorable apatite formation and angiogenesis Improved osteogenesis and cementogenesis compared to HA and TCP |
37 |
Silicocarnotite (Ca2SiO4.Ca(PO4)2) | Alveolar bone, cementum | Better mechanical properties and manufacturability compared to Nagelschmidtite Better bone formation, osteogenesis, and cementogenesis compared to the HA |
37 |
Nurse's Ass-phase (2Ca2SiO4.Ca3(PO4)2) | Alveolar bone, cementum | Favorable bone formation and degradation rate Lower bone formation compares to other Silicate based bioceramics |
37 |
Other silicate-based bioceramics: | Alveolar bone, cementum | Great cellular properties Excellent ability in improving cell proliferation and differentiation to osteogenic of PDLCs Great cementum formation compares to other bioceramics Increasing expression of osteocalcin and bone sialoprotein |
30 |
Akermanite (Ca2MgSi2O7) | |||
Bredigite (Ca7MgSi4O16) | |||
Baghdadite (Ca3ZrSi2O9) | |||
Diopside (CaMgSi2O6) |